Summit Therapeutics Inc Stock Institutional Ownership and Insider Ownership -
737.45
(Mil)
Shares Outstanding
12.55%
92.50 (Mil)
Institutional Ownership
16.11%
118.8061 (Mil)
Float Percentage of TSO
Short Interest History (%)
Due to a license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus’ website, except for certain Australian stocks.
Institutional Ownership History (%)
This the Institutional Ownership History of Summit Therapeutics Inc. Peter Lynch prefers to buy companies with low institutional ownership.
* Due to varying ownership data coverage and corporate events such as splits, the information in this section is in no way guaranteed for completeness, accuracy or in any other way.
Insider ownership (%)
This is the historical insider ownership of Summit Therapeutics Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.
1. Please note that our data vendor collects insider data for officers and directors from Forms 3,4,5 and amendments where they only capture direct ownership data, not indirect ownership.
1. Please note that our data vendor collects insider data for officers and directors from Forms 3,4,5 and amendments where they only capture direct ownership data, not indirect ownership.
* Due to varying ownership data coverage and corporate events such as splits, the information in this section is in no way guaranteed for completeness, accuracy or in any other way.
Top Direct Holders
Top Fund Holders
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers